Careers LGP Global
Little Green Pharma
  • Home
  • About Us
    • About Us
    • CEO Update on Financial Results
    • LGP Denmark
    • Leadership Team
    • GMP Manufacturing Capabilities
    • Governance
    • Partners
  • Projects
    • Australian Expansion
    • French Update
    • Global Expansion
    • Research & Development
    • Education
  • Investor Centre
    • Share Purchase Plan (SPP)
    • Investor Welcome
    • Investor Presentations
    • ASX Announcements
    • Quarterly Reports
    • Annual & Half Yearly Reports
    • Corporate Governance Statement
    • Annual General Meetings
      • Market Research
    • Extraordinary General Meetings
    • Corporate Directory
    • Cannabis wrap
    • ASIC Guidance
    • Share Price Information
    • Email Alerts
  • Media
    • Media
  • Contact
    • Contact Details
    • Newsletter sign up
  • Home
  • About Us
  • Projects
  • Investor Centre
  • Media
  • Contact
    Menu Section List
    Investor Centre

    Investor Centre

    Information to assist those interested in investing in Little Green Pharma Ltd.

    Learn More
    Home > Investor Centre > ASX Announcements
    • Share Purchase Plan (SPP)
    • Investor Welcome
    • Investor Presentations
    • ASX Announcements
    • Quarterly Reports
    • Annual & Half Yearly Reports
    • Corporate Governance Statement
    • Annual General Meetings
      • Market Research
    • Extraordinary General Meetings
    • Corporate Directory
    • Cannabis wrap
    • ASIC Guidance
    • Share Price Information
    • Email Alerts

    ASX Announcements

    Filter by Year:2025 2024 2023 2022 
    22 Jun 2021
    Investor Presentation - Denmark acquisition & capital raise
    22 Jun 2021
    LGP acquires Denmark facility and undertakes share placement
    21 Jun 2021
    Trading Halt
    17 Jun 2021
    Exclusive distribution partner - leading Polish pharma group
    17 Jun 2021
    Letter to Shareholders regarding General Meeting
    17 Jun 2021
    Notice of General Meeting
    15 Jun 2021
    Update to Sales and Distribution in Australia and Germany
    10 Jun 2021
    Becoming a substantial holder - Tiga Trading Pty Ltd
    28 May 2021
    Results of Meeting
    27 May 2021
    $2.5m firm order increases expected DEMECAN revenue to $5.7m
    • Previous 
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    •  Next

    Sign up to our newsletter

    Sign up!

    Quick Links

    Contact Us

    Head Office:
    PO Box 101, Wembley,
    Perth WA 6913
    Ph: +61 8 6280 0050
    info@littlegreenpharma.com

    Follow Us

    Copyright © Little Green Pharma
    Site Map Privacy Search
    Site by

    Email Alerts

    Get the latest company news

    Which of the following group do you best fit?